AVAH

Aveanna Healthcare Holdings, Inc.

Export transactions ↓

Tapewire entity: 4246
SEC CIK: 0001832332
Parsed reports: 203

Last 12 months

Inside the activity.

0 purchase rows · 71 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.

Nov

Dec

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Monthly counts

Month	Purchases	Sales
Nov 2025	0	0
Dec 2025	0	10
Jan 2026	0	5
Feb 2026	0	15
Mar 2026	0	0
Apr 2026	0	0
May 2026	0	1
Jun 2026	0	21
Jul 2026	0	0
Aug 2026	0	19
Sep 2026	0	0
Oct 2026	0	0

Latest available

Insider transactions

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Owner / reported role	Activity / security	Shares / units	Reported price	Reported value	Details
March 25, 2025 Filed Mar 26, 2025 23:21 UTC	WILLIAMS ROBERT M JR10% owner	SaleCommon Stock, $0.01 par value	116	$5.64	$654.24	Disclosure SEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 3 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,387,870 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 25, 2025 Filed Mar 26, 2025 23:21 UTC	J.H. Whitney Equity Partners VII, LLC10% owner	SaleCommon Stock, $0.01 par value	5	$5.64	$28.20	Disclosure SEC source: 0000950170-25-045583 · ownership.xml · nonDerivative · entry 7 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,765 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 25, 2025 Filed Mar 26, 2025 23:21 UTC	J.H. Whitney Equity Partners VII, LLC10% owner	SaleCommon Stock, $0.01 par value	58	$5.64	$327.12	Disclosure SEC source: 0000950170-25-045583 · ownership.xml · nonDerivative · entry 5 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,716 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 25, 2025 Filed Mar 26, 2025 23:21 UTC	J.H. Whitney Equity Partners VII, LLC10% owner	SaleCommon Stock, $0.01 par value	116	$5.64	$654.24	Disclosure SEC source: 0000950170-25-045583 · ownership.xml · nonDerivative · entry 3 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,387,870 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:18 UTC	VIGANO PAUL R10% owner	SaleCommon Stock, $0.01 par value	3	$5.63	$16.89	Disclosure SEC source: 0000950170-25-045579 · ownership.xml · nonDerivative · entry 10 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 546,454 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:18 UTC	VIGANO PAUL R10% owner	SaleCommon Stock, $0.01 par value	8	$5.63	$45.04	Disclosure SEC source: 0000950170-25-045579 · ownership.xml · nonDerivative · entry 8 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,770 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:18 UTC	VIGANO PAUL R10% owner	SaleCommon Stock, $0.01 par value	29	$5.63	$163.27	Disclosure SEC source: 0000950170-25-045579 · ownership.xml · nonDerivative · entry 6 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,213,065 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:18 UTC	VIGANO PAUL R10% owner	SaleCommon Stock, $0.01 par value	87	$5.63	$489.81	Disclosure SEC source: 0000950170-25-045579 · ownership.xml · nonDerivative · entry 4 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,774 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:18 UTC	VIGANO PAUL R10% owner	SaleCommon Stock, $0.01 par value	173	$5.63	$973.99	Disclosure SEC source: 0000950170-25-045579 · ownership.xml · nonDerivative · entry 2 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,387,986 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:21 UTC	WILLIAMS ROBERT M JR10% owner	SaleCommon Stock, $0.01 par value	3	$5.63	$16.89	Disclosure SEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 10 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 546,454 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:21 UTC	WILLIAMS ROBERT M JR10% owner	SaleCommon Stock, $0.01 par value	8	$5.63	$45.04	Disclosure SEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 8 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,770 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:21 UTC	WILLIAMS ROBERT M JR10% owner	SaleCommon Stock, $0.01 par value	29	$5.63	$163.27	Disclosure SEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 6 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,213,065 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:21 UTC	WILLIAMS ROBERT M JR10% owner	SaleCommon Stock, $0.01 par value	87	$5.63	$489.81	Disclosure SEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 4 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,774 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:21 UTC	WILLIAMS ROBERT M JR10% owner	SaleCommon Stock, $0.01 par value	173	$5.63	$973.99	Disclosure SEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,387,986 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:21 UTC	J.H. Whitney Equity Partners VII, LLC10% owner	SaleCommon Stock, $0.01 par value	8	$5.63	$45.04	Disclosure SEC source: 0000950170-25-045583 · ownership.xml · nonDerivative · entry 6 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,770 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:21 UTC	J.H. Whitney Equity Partners VII, LLC10% owner	SaleCommon Stock, $0.01 par value	87	$5.63	$489.81	Disclosure SEC source: 0000950170-25-045583 · ownership.xml · nonDerivative · entry 4 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,774 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:21 UTC	J.H. Whitney Equity Partners VII, LLC10% owner	SaleCommon Stock, $0.01 par value	173	$5.63	$973.99	Disclosure SEC source: 0000950170-25-045583 · ownership.xml · nonDerivative · entry 2 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,387,986 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 20:11 UTC	J.H. Whitney Equity Partners VII, LLC10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner PSA Iliad Holdings LLC10% owner	SaleCommon Stock, $0.01 par value	2,170	$5.46	$11,848.20	Disclosure SEC source: 0000950170-25-042870 · ownership.xml · nonDerivative · entry 7 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,778 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 20:11 UTC	J.H. Whitney Equity Partners VII, LLC10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner PSA Iliad Holdings LLC10% owner	SaleCommon Stock, $0.01 par value	23,438	$5.46	$127,971.48	Disclosure SEC source: 0000950170-25-042870 · ownership.xml · nonDerivative · entry 5 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,861 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 20:11 UTC	J.H. Whitney Equity Partners VII, LLC10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner PSA Iliad Holdings LLC10% owner	SaleCommon Stock, $0.01 par value	46,912	$5.46	$256,139.52	Disclosure SEC source: 0000950170-25-042870 · ownership.xml · nonDerivative · entry 3 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,388,159 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	817	$5.46	$4,460.82	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 11 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 546,457 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	2,170	$5.46	$11,848.20	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 9 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,778 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	7,792	$5.46	$42,544.32	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 7 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,213,094 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	23,438	$5.46	$127,971.48	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 5 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,861 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	46,912	$5.46	$256,139.52	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 3 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,388,159 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	817	$5.46	$4,460.82	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 11 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 546,457 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	2,170	$5.46	$11,848.20	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 9 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,778 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	7,792	$5.46	$42,544.32	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 7 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,213,094 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	23,438	$5.46	$127,971.48	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 5 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,861 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 19, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	46,912	$5.46	$256,139.52	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 3 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,388,159 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 20:11 UTC	J.H. Whitney Equity Partners VII, LLC10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner PSA Iliad Holdings LLC10% owner	SaleCommon Stock, $0.01 par value	1,842	$5.51	$10,149.42	Disclosure SEC source: 0000950170-25-042870 · ownership.xml · nonDerivative · entry 6 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · PSA Iliad Holdings LLC Disclosed balance after: 1,453,948 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 20:11 UTC	J.H. Whitney Equity Partners VII, LLC10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner PSA Iliad Holdings LLC10% owner	SaleCommon Stock, $0.01 par value	19,897	$5.51	$109,632.47	Disclosure SEC source: 0000950170-25-042870 · ownership.xml · nonDerivative · entry 4 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,705,299 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 20:11 UTC	J.H. Whitney Equity Partners VII, LLC10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner PSA Iliad Holdings LLC10% owner	SaleCommon Stock, $0.01 par value	39,825	$5.51	$219,435.75	Disclosure SEC source: 0000950170-25-042870 · ownership.xml · nonDerivative · entry 2 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,435,071 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	693	$5.51	$3,818.43	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 10 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 547,274 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	1,842	$5.51	$10,149.42	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 8 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,453,948 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	6,614	$5.51	$36,443.14	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 6 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,220,886 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	19,897	$5.51	$109,632.47	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 4 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,705,299 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 20:05 UTC	WILLIAMS ROBERT M JR10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	39,825	$5.51	$219,435.75	Disclosure SEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,435,071 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	693	$5.51	$3,818.43	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 10 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 547,274 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	1,842	$5.51	$10,149.42	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 8 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,453,948 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	6,614	$5.51	$36,443.14	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 6 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,220,886 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	19,897	$5.51	$109,632.47	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 4 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,705,299 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
March 18, 2025 Filed Mar 20, 2025 19:59 UTC	VIGANO PAUL R10% owner J.H. Whitney VII, L.P.10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC10% owner JHW Iliad Holdings LLC10% owner PSA Iliad Holdings LLC10% owner JHW Iliad Holdings II LLC10% owner	SaleCommon Stock, $0.01 par value	39,825	$5.51	$219,435.75	Disclosure SEC source: 0000950170-25-042859 · ownership.xml · nonDerivative · entry 2 VIGANO PAUL R · CIK 0001239606 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,435,071 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC") , the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document
February 28, 2025 Filed Mar 4, 2025 21:48 UTC	Perchik JerryChief Legal Officer, Secretary	GrantCommon Stock, par value $0.01 per share	85,598	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032989 · ownership.xml · nonDerivative · entry 1 Perchik Jerry · CIK 0002020493 · Chief Legal Officer, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,980 F1 · price: Grant of stock-settled restricted stock unit ("RSUs"), subject to three-year cliff vesting. F2 · balance_after: Includes grant of 882 RSUs that were inadvertently omitted from the reporting person's Form 4 filed on April 30, 2024. Read SEC document
February 28, 2025 Filed Mar 5, 2025 02:47 UTC	Schwartz EricaDirector	GrantCommon Stock, par value $0.01 per share	28,261	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032983 · ownership.xml · nonDerivative · entry 1 Schwartz Erica · CIK 0001872122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,498 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document
February 28, 2025 Filed Mar 4, 2025 21:45 UTC	LAYTON BRENT DDirector	GrantCommon Stock, par value $0.01 per share	28,261	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032974 · ownership.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,342 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document
February 28, 2025 Filed Mar 4, 2025 21:47 UTC	Retchin Sheldon MDirector	GrantCommon Stock, par value $0.01 per share	28,261	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032985 · ownership.xml · nonDerivative · entry 1 Retchin Sheldon M · CIK 0001470958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 324,746 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document
February 28, 2025 Filed Mar 4, 2025 21:45 UTC	RODGERS STEVEN EDirector	GrantCommon Stock, par value $0.01 per share	28,261	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032976 · ownership.xml · nonDerivative · entry 1 RODGERS STEVEN E · CIK 0001239604 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,498 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document
February 28, 2025 Filed Mar 4, 2025 21:48 UTC	GANZI VICTOR FDirector	GrantCommon Stock, par value $0.01 per share	28,261	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032990 · ownership.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,606 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document
February 28, 2025 Filed Mar 5, 2025 02:49 UTC	Windley Rodney DDirector	GrantCommon Stock, par value $0.01 per share	32,609	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032992 · ownership.xml · nonDerivative · entry 1 Windley Rodney D · CIK 0001354351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,028,287 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. F2 · balance_after: Includes 36,000 shares purchased on May 19, 2022 reported by the reporting person on a Form 4 filed on May 20, 2022, which was inadvertently omitted from the reporting person's subsequent Forms 4 and excludes 119,048 shares issued upon the settlement of restricted stock units granted to the reporting person on February 14, 2023, which were reported as acquired on a Form 4 filed by the reporting person on February 20, 2024 in duplication of the acquisition of such shares previously reported in Table I of the Form 4 filed by the reporting person on February 16, 2023. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.